Keyword: Johnson & Johnson

News

Tylenol: J&J Recalls Incorrectly Labeled Products

25.11.2010 - Johnson & Johnson said on Wednesday it is recalling 9 million more bottles of its Tylenol painkiller because they do not adequately warn customers about the presence of trace...

News

Plunging J&J Consumer Sales Hurt Results

20.10.2010 - Johnson & Johnson on Tuesday reported disappointing quarterly revenue as sales of U.S. consumer products plunged 25% following recalls of Tylenol and other consumer brands, driving...

News

Musty Odor Sparks Another Tylenol Recall

19.10.2010 - A moldy odor has again stricken Johnson & Johnson's Tylenol, and the company is recalling another lot of the over-the-counter painkiller. J&J, which has recalled tens of millions...

Chemistry & Life Sciences

Live And Learn

06.10.2010 - Hamlet's Quandary - To train or not to train, that is the question. If the answer to this question is yes, then further questions arise such as what type of training is appropriate...

News

J&J CEO To Testify On Recalls; Tylenol Brand Dips

29.09.2010 - Johnson & Johnson's massive recall of popular medicines, including a stealthy recall of some Motrin packages, has eroded the company's reputation and put pressure on chief...

News

J&J Drug Executive Assumes Consumer Unit Oversight

19.08.2010 - A senior Johnson & Johnson pharmaceuticals executive will now also oversee the company's consumer healthcare unit, following quality control lapses that led to massive recalls of...

News

Sanofi Investors Oppose Big Hike In Genzyme Bid

04.08.2010 - Sanofi-Aventis investors have urged the drugmaker not to pay more than about $19 billion to land Genzyme, some $10 a share below the price wanted by the U.S. biotech group. Two...

News

Sanofi Shareholders Want Genzyme For About $19 Billion

03.08.2010 - Sanofi-Aventis chief executive Chris Viehbacher should aim to land U.S. biotech group Genzyme for around$19 billion to keep his investors on side, according to institutional...